10.01.2011 • NewsLonzaStefan Borgasstrong Swiss franc

Stefan Borgas: Strong Franc Major Challenge for Swiss Economy

Stefan Borgas, CEO of Lonza, warns that a strong Swiss franc will have a...
Stefan Borgas, CEO of Lonza, warns that a strong Swiss franc will have a negative effect on the country's industry.

The strong Swiss franc will be a major challenge for the Swiss economy in the next five years, Lonza Chief Executive Stefan Borgas was quoted as saying in a newspaper interview on Friday.

"(The strong franc) is going to be one of the fundamental challenges for the country in the next five years and nobody is getting ready for that," the head of the Swiss drugs industry supplier said in an interview with Swiss newspaper Finanz und Wirtschaft.

"(Swiss companies) will see zero growth. If operational costs rise 10-15% every year, you cannot make up for that with innovation and technology: products made in Switzerland will not be competitive anymore on a global scale," he said.

The Swiss franc rose about 16 % versus the euro last year, hitting Switzerland's export-oriented economy.

Industry leaders like Swatch Group Chief Executive Nick Hayek have warned of the far-reaching consequences the currency situation can have for the country's economy.

Company

Logo:

Lonza AG

Muenchensteinerstrasse 38
4002 Basel
Switzerland

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.